These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19909203)

  • 21. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
    Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
    J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S; Swyer GI; Lawrence DM
    Acta Eur Fertil; 1977 Dec; 8(4):297-9. PubMed ID: 610314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
    Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?
    Greenstein A; Mabjeesh NJ; Sofer M; Kaver I; Matzkin H; Chen J
    J Urol; 2005 Feb; 173(2):530-2. PubMed ID: 15643239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation.
    Giltay EJ; Haider A; Saad F; Gooren LJ
    Andrologia; 2008 Dec; 40(6):398-400. PubMed ID: 19032692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?].
    Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M
    Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
    Moisey R; Swinburne J; Orme S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate.
    Minnemann T; Schubert M; Hübler D; Gouni-Berthold I; Freude S; Schumann C; Oettel M; Ernst M; Mellinger U; Sommer F; Krone W; Jockenhövel F
    Aging Male; 2007 Sep; 10(3):155-8. PubMed ID: 17701659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of various modes of androgen substitution therapy on erythropoiesis.
    Jockenhövel F; Vogel E; Reinhardt W; Reinwein D
    Eur J Med Res; 1997 Jul; 2(7):293-8. PubMed ID: 9233903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple self-report diary for assessing psychosexual function in hypogonadal men.
    Lee KK; Berman N; Alexander GM; Hull L; Swerdloff RS; Wang C
    J Androl; 2003; 24(5):688-98. PubMed ID: 12954659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.
    Kwan M; Greenleaf WJ; Mann J; Crapo L; Davidson JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):557-62. PubMed ID: 6874890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypogonadism and cardiovascular diseases in men].
    Ter Arkh; 2011; 83(10):61-7. PubMed ID: 22185029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men.
    Anderson RA; Martin CW; Kung AW; Everington D; Pun TC; Tan KC; Bancroft J; Sundaram K; Moo-Young AJ; Baird DT
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3556-62. PubMed ID: 10522995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men.
    Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B
    Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.